U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

Scientists from Drexel University’s College of Medicine and Columbia University’s Irving Medical Center have uncovered a ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and ...

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

AI has advanced molecule design, yet synthetic feasibility remains a bottleneck. Chemistry-first approaches offer a practical ...

Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...

Peptilogics Founder, CEO, Jonathan Steckbeck, explained that PLG0206 stands apart from current treatments, while the ...

AI and SPARK platform integration accelerates cancer research by analyzing diverse health data for early detection and ...

Trials should assess overall survival to evaluate potential harm, with crossover limited to avoid confounding treatment ...